1
Qib
Shares bid 9,73,17,000 · Offered 5,40,000
180.22×
listed · IPO · BSE SME · listed 18 May 2026
GOLDLINE PHARMACEUTICAL LIMITED
Raised ₹8.46 Cr at ₹43 per share.
+32.0%
listing-day move
Price band
₹41 – ₹43
Issue price
₹43
Shares per lot
3,000
Retail minimum
₹1,29,000
Issue size
₹8.46 Cr
Face value
₹10
Listing-day close
₹56.77
Current price
₹43.95
Return since listing
+2.21%
Subscription by investor category
as of 23 May, 22:10 ISTTotal demand
— shares bid
781.85×
2
Qib Fii
Shares bid 2,54,37,000
2,54,37,000 shares
3
Qib Dfi
Shares bid 9,000
9,000 shares
4
Qib Mf
— shares
5
Qib Other
Shares bid 7,18,71,000
7,18,71,000 shares
6
Nii
Shares bid 64,83,33,000 · Offered 5,28,000
1,227.9×
7
Nii Gt 10l
Shares bid 51,88,74,000 · Offered 2,58,000
2,011.14×
8
Nii Lte 10l
Shares bid 12,94,59,000 · Offered 1,32,000
980.75×
9
Retail
Shares bid 79,30,38,000 · Offered 9,00,000
881.15×
10
Employee
Shares bid 0
0 shares
11
Shareholder
Shares bid 0
0 shares
12
Policyholder
Shares bid 0
0 shares
Exchange filings
Fields captured from NSE and BSEIssue information
- Symbol
- GPL03
- Issue size
- 19,68,000 shares
- Price range
- Rs.41 to Rs.43
- Lot size
- 3000
- Face value
- Rs.10
- Tick size
- Rs.1
- Book running lead managers
- Cumulative Capital Private Limited
- Sponsor bank
- AXIS BANK
- Name of the Registrar
- Bigshare Services Private Limited
Parties to the issue
Book-running lead manager
Cumulative Capital Private Limited
Registrar
Bigshare Services Private Limited
Sponsor bank
AXIS BANK
Data sources: BSE , BSE , BSE , BSE , BSE , MONEYCONTROL . Data quality clean.